Skip to content

Laboratory progression of D-dimers in elective total hip arthroplasty.

Laboratory progression of D-dimers in elective total hip arthroplasty. - D-Dimer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00024934
Enrollment
150
Registered
2021-04-16
Start date
2021-04-12
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M16

Interventions

Group 1: D-dimer progression in selective total hip arthroplasty at Cologne University Hospital Group 2: D-dimer progression in selective total hip arthroplasty at Helios Klinikum Krefeld

Sponsors

Uniklinik Köln
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Presence of the signed consent form - Patients suffering from osteoarthritis of the hip joint for which a total hip replacement has been medically indicated. - Patients who are cognitively and linguistically able to read and understand the information of the study and its questions. - Patients suffering from moderate to severe symptoms originating from the affected hip (min. VAS = 4) - Patients with an age of more than 18 years

Exclusion criteria

Exclusion criteria: - Failure to meet inclusion criteria - Patient refusal - Incapacity of the patient to give consent - Insufficient knowledge of German, or insufficient understanding of the study - Lack of medical indication for implantation of total hip arthroplasty - History of infection of the leg to be operated on - Previous surgery on the affected leg within the last 6 months - Presence of rheumatoid arthritis - Current tumor therapy or tumor disease - Current deep vein thrombosis

Design outcomes

Primary

MeasureTime frame
Endpoint of the volunteer: 3 laboratory tests, which are determined. Laboratory testing of D-dimers: 1st preoperatively (admission laboratory). 2. on the 1st postoperative day (routine laboratory post-op) 3. on postoperative day 5-8 or before discharge. Study Objective: 75 subjects per arm

Countries

Germany

Contacts

Public ContactTobias Seidel

Uniklinik Köln

tobias.seidel@uk-koeln.de0221/4780

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026